Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases

BACKGROUND: Very little is known about the impact of the wash-out period on the pharmacokinetics of a second-line biologic. OBJECTIVE: The objective of this article is to explore the impact of two different wash-out periods on the pharmacokinetics of vedolizumab and infliximab. METHODS: Patients swi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:United European Gastroenterol J
Autors principals: Liefferinckx, Claire, Verstockt, Bram, Gils, Ann, Tops, Sophie, Van Moerkercke, Wouter, Vermeire, Severine, Franchimont, Denis
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620879/
https://ncbi.nlm.nih.gov/pubmed/31316779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619841538
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars